The global Cetuximab market size was valued at US$ 1.89 billion in 2024 and is projected to reach US$ 2.34 billion by 2030, at a CAGR of 3.6% during the forecast period 2024-2030.
United States Cetuximab market size was valued at US$ 615 million in 2024 and is projected to reach US$ 735 million by 2030, at a CAGR of 3.0% during the forecast period 2024-2030.
Monoclonal antibody used to treat colorectal cancer and head and neck cancer.
Moderate growth driven by expanding use in combination therapies. Increasing competition from newer targeted therapies and immunotherapies. Ongoing research into biomarkers for patient selection improving efficacy.
Report Overview
Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer.
This report provides a deep insight into the global Cetuximab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cetuximab Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cetuximab market in any manner.
Global Cetuximab Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eli Lilly
Merck
Market Segmentation (by Type)
100 mg/50 mL Injection
200 mg/100 mL Injection
Market Segmentation (by Application)
Head and Neck Cancer
Metastatic Colorectal Cancer
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cetuximab Market
Overview of the regional outlook of the Cetuximab Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cetuximab
1.2 Key Market Segments
1.2.1 Cetuximab Segment by Type
1.2.2 Cetuximab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cetuximab Market Overview
2.1 Global Market Overview
2.1.1 Global Cetuximab Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cetuximab Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cetuximab Market Competitive Landscape
3.1 Global Cetuximab Sales by Manufacturers (2019-2024)
3.2 Global Cetuximab Revenue Market Share by Manufacturers (2019-2024)
3.3 Cetuximab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cetuximab Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cetuximab Sales Sites, Area Served, Product Type
3.6 Cetuximab Market Competitive Situation and Trends
3.6.1 Cetuximab Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cetuximab Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Cetuximab Industry Chain Analysis
4.1 Cetuximab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cetuximab Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Cetuximab Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cetuximab Sales Market Share by Type (2019-2024)
6.3 Global Cetuximab Market Size Market Share by Type (2019-2024)
6.4 Global Cetuximab Price by Type (2019-2024)
7 Cetuximab Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cetuximab Market Sales by Application (2019-2024)
7.3 Global Cetuximab Market Size (M USD) by Application (2019-2024)
7.4 Global Cetuximab Sales Growth Rate by Application (2019-2024)
8 Cetuximab Market Segmentation by Region
8.1 Global Cetuximab Sales by Region
8.1.1 Global Cetuximab Sales by Region
8.1.2 Global Cetuximab Sales Market Share by Region
8.2 North America
8.2.1 North America Cetuximab Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cetuximab Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cetuximab Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cetuximab Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cetuximab Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Eli Lilly
9.1.1 Eli Lilly Cetuximab Basic Information
9.1.2 Eli Lilly Cetuximab Product Overview
9.1.3 Eli Lilly Cetuximab Product Market Performance
9.1.4 Eli Lilly Business Overview
9.1.5 Eli Lilly Cetuximab SWOT Analysis
9.1.6 Eli Lilly Recent Developments
9.2 Merck
9.2.1 Merck Cetuximab Basic Information
9.2.2 Merck Cetuximab Product Overview
9.2.3 Merck Cetuximab Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Cetuximab SWOT Analysis
9.2.6 Merck Recent Developments
10 Cetuximab Market Forecast by Region
10.1 Global Cetuximab Market Size Forecast
10.2 Global Cetuximab Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cetuximab Market Size Forecast by Country
10.2.3 Asia Pacific Cetuximab Market Size Forecast by Region
10.2.4 South America Cetuximab Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cetuximab by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Cetuximab Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cetuximab by Type (2025-2030)
11.1.2 Global Cetuximab Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cetuximab by Type (2025-2030)
11.2 Global Cetuximab Market Forecast by Application (2025-2030)
11.2.1 Global Cetuximab Sales (Kilotons) Forecast by Application
11.2.2 Global Cetuximab Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cetuximab Market Size Comparison by Region (M USD)
Table 5. Global Cetuximab Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Cetuximab Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cetuximab Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cetuximab Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cetuximab as of 2022)
Table 10. Global Market Cetuximab Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cetuximab Sales Sites and Area Served
Table 12. Manufacturers Cetuximab Product Type
Table 13. Global Cetuximab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cetuximab
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cetuximab Market Challenges
Table 22. Global Cetuximab Sales by Type (Kilotons)
Table 23. Global Cetuximab Market Size by Type (M USD)
Table 24. Global Cetuximab Sales (Kilotons) by Type (2019-2024)
Table 25. Global Cetuximab Sales Market Share by Type (2019-2024)
Table 26. Global Cetuximab Market Size (M USD) by Type (2019-2024)
Table 27. Global Cetuximab Market Size Share by Type (2019-2024)
Table 28. Global Cetuximab Price (USD/Ton) by Type (2019-2024)
Table 29. Global Cetuximab Sales (Kilotons) by Application
Table 30. Global Cetuximab Market Size by Application
Table 31. Global Cetuximab Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Cetuximab Sales Market Share by Application (2019-2024)
Table 33. Global Cetuximab Sales by Application (2019-2024) & (M USD)
Table 34. Global Cetuximab Market Share by Application (2019-2024)
Table 35. Global Cetuximab Sales Growth Rate by Application (2019-2024)
Table 36. Global Cetuximab Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Cetuximab Sales Market Share by Region (2019-2024)
Table 38. North America Cetuximab Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Cetuximab Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Cetuximab Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Cetuximab Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Cetuximab Sales by Region (2019-2024) & (Kilotons)
Table 43. Eli Lilly Cetuximab Basic Information
Table 44. Eli Lilly Cetuximab Product Overview
Table 45. Eli Lilly Cetuximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Eli Lilly Business Overview
Table 47. Eli Lilly Cetuximab SWOT Analysis
Table 48. Eli Lilly Recent Developments
Table 49. Merck Cetuximab Basic Information
Table 50. Merck Cetuximab Product Overview
Table 51. Merck Cetuximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Cetuximab SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Global Cetuximab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Global Cetuximab Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America Cetuximab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. North America Cetuximab Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe Cetuximab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 60. Europe Cetuximab Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific Cetuximab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Asia Pacific Cetuximab Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America Cetuximab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. South America Cetuximab Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa Cetuximab Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa Cetuximab Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global Cetuximab Sales Forecast by Type (2025-2030) & (Kilotons)
Table 68. Global Cetuximab Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global Cetuximab Price Forecast by Type (2025-2030) & (USD/Ton)
Table 70. Global Cetuximab Sales (Kilotons) Forecast by Application (2025-2030)
Table 71. Global Cetuximab Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Cetuximab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cetuximab Market Size (M USD), 2019-2030
Figure 5. Global Cetuximab Market Size (M USD) (2019-2030)
Figure 6. Global Cetuximab Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cetuximab Market Size by Country (M USD)
Figure 11. Cetuximab Sales Share by Manufacturers in 2023
Figure 12. Global Cetuximab Revenue Share by Manufacturers in 2023
Figure 13. Cetuximab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cetuximab Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cetuximab Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cetuximab Market Share by Type
Figure 18. Sales Market Share of Cetuximab by Type (2019-2024)
Figure 19. Sales Market Share of Cetuximab by Type in 2023
Figure 20. Market Size Share of Cetuximab by Type (2019-2024)
Figure 21. Market Size Market Share of Cetuximab by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cetuximab Market Share by Application
Figure 24. Global Cetuximab Sales Market Share by Application (2019-2024)
Figure 25. Global Cetuximab Sales Market Share by Application in 2023
Figure 26. Global Cetuximab Market Share by Application (2019-2024)
Figure 27. Global Cetuximab Market Share by Application in 2023
Figure 28. Global Cetuximab Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cetuximab Sales Market Share by Region (2019-2024)
Figure 30. North America Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Cetuximab Sales Market Share by Country in 2023
Figure 32. U.S. Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Cetuximab Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Cetuximab Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Cetuximab Sales Market Share by Country in 2023
Figure 37. Germany Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Cetuximab Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Cetuximab Sales Market Share by Region in 2023
Figure 44. China Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Cetuximab Sales and Growth Rate (Kilotons)
Figure 50. South America Cetuximab Sales Market Share by Country in 2023
Figure 51. Brazil Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Cetuximab Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Cetuximab Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Cetuximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Cetuximab Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Cetuximab Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cetuximab Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cetuximab Market Share Forecast by Type (2025-2030)
Figure 65. Global Cetuximab Sales Forecast by Application (2025-2030)
Figure 66. Global Cetuximab Market Share Forecast by Application (2025-2030)
